Ankylosing Spondylitis Trial, Recruiting NCT06967883 Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Ankylosing Spondylitis Trial, Recruiting

NCT06967883
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old.
  • You have been diagnosed with Ankylosing Spondylitis (a type of inflammatory arthritis affecting the spine) using a specific set of medical guidelines called the Modified New York Criteria (this applies to the patient group).
  • You are able to understand and follow instructions for the tests involved in the study.

Who may not be able to join:

  • You have a bone or joint condition that affects your spine or legs.
  • You have a heart or blood vessel condition.
  • You have a condition affecting your brain or nervous system.
  • You have problems with your vision or hearing.
  • You have had surgery on your spine or legs in the past.
  • You have been diagnosed with a psychiatric (mental health) condition.
  • You have difficulties with memory, thinking, or understanding (cognitive impairment).
  • You have signs or symptoms of a pinched nerve in your neck, such as pain, numbness, or weakness spreading into your arms (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nurdan Paker, MD, Prof., Istanbul Physical Medicine and Rehabilitation Training Research Hospital

Phone: 90+5353440933

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 September 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Mean Bilateral Thickness of Cervical Multifidus Muscle Assessed by Ultrasonography; Mean Bilateral Thickness of Cervical Longus Colli Muscle Assessed by Ultrasonography; Limits of Stability (LOS) Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov